Shopping, Retail News & Press Release Distribution Services
GroupWeb News Network
Africa
Alabama
Alaska
Arizona
Arkansas
Asia
California
China
Colorada
Connecticut
Washington DC
Delaware
Florida
France
Georgia
Germany
Ghana
Hawaii
Idaho
Illinois
India
Indiana
Iowa
Italy
Japan
Kansas
Kentucky
Korea
Lousiana
Main
MaryLand
Massachusetts
Michigan
Minnesota
Mississippi
Misouri
Motana
Nebraska
Nevad
New Hampshire
New Jersey
New Mexico
New York
Nigeria
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
Rhode Island
Russia
South Africa
South Carolina
South Dakota
Spain
Tennessee
Texas
UK
Utah
Vermont
Virginia
Washington
Weather
West Virginia
Wisconsin
Submit RSS Feed
|
About US
|
Contact Us
Home
|
Retail News
|
Submit Press Release
Unlimited Press Release Distribution
News Media List
MSNBC Retail News
Financial Times
Internet Retailer
Luxury Daily
New York Times
Planet Retail
Retail Technology Review
Retail Bulletin
Supermarket News
Special Retail Report
Women's Wear Daily
RSS News Feed
Get your news feed listed here as other news media shown above!
Submit RSS News Feed
Retail, Shopping News Releases
Search retail news:
Prostate Specific Antigen Global Atherosclerosis Clinical Trials Rise Due to Higher Disease Incidences Pipeline, H1 Review Till 2017
Market Research Hub - Market Research Company
(
Shopping-NewsWire.com
, June 24, 2017 ) Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Prostate-specific antigen (PSA) is a glycoprotein enzyme encoded by the KLK3 gene. PSA is secreted by the epithelial cells of the prostate gland. It is hydrolyzes semenogelin-1 this leads to the liquefaction of the seminal coagulum.
Request For Free Sample @
http://www.marketresearchhub.com/enquiry.php?type=S&repid=1177486
Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) pipeline Target constitutes close to 12 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 1, 1, 2, 1 and 4 respectively. Similarly, the universities portfolio in Phase II stages comprises 3 molecules, respectively. Report covers products from therapy areas Oncology which include indications Prostate Cancer, Metastatic Hormone Refractory (Castration Resistant and Androgen-Independent) Prostate Cancer.
The “
latest report Prostate Specific Antigen Pipeline Review
” , H1 2017, outlays comprehensive information on the Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) targeted therapeutics development with respective active and dormant or discontinued projects.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the global therapeutic landscape for Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77)
- The report reviews Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) targeted therapeutics and enlists all their major and minor projects
- The report assesses Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) targeted therapeutics
Browse Full Report With TOC @
http://www.marketresearchhub.com/report/prostate-specific-antigen-gamma-seminoprotein-or-kallikrein-3-or-p-30-antigen-or-semenogelase-or-klk3-or-ec-342177-pipeline-review-h1-2017-report.html
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Make an Enquiry:
http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1177486
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website:
http://www.marketresearchhub.com/
Read More Related News:
https://www.industrynewsanalysis.com/
Market Research Hub
Sudip S
+1-518-621-2074
sales@marketresearchhub.com
Source:
EmailWire.Com
Retail News by Sector
Accessories
Department Stores
Fashion
Home/Household
Entertainment
M Commerce
Online Retail
Retail Magazines
Retail Issues
Store Design
Sign-Up To Our Free Newsletter!
Shopping and Retail NewsWire
Retail RSS Marketpalce
Target Press Releases
News releases from Target. Second retail giant in America.
Free Food & Beverage Magazines and Downloads
Get free publications including magazines, white papers about the food and beverage industry.
Submit RSS news feed on Retail, Shopping
.
Have your feed on news, products or services displayed under this marketpalce. The feed also displayed on a full page and updated daily.
Add RSS feed Now!
Shopping-Newswire is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.
For unlimited press release distribution for $99 per month or $999 per year, call (281) 645-4086 or start posting your press releases online at
EmailWire.com
.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network
AfricaNewswire.Net
|
AppleNews247.Com> |
AsiaNewsWire.Net
|
Aviation-NewsWire> |
Energy Industry
|
EstateNewsWire
|
Entertainment-NewsWire.com
|
Food Beverage News
|
Glamour NewsWire
|
Health NewsWire
|
Hosting NewsWire
|
i-Auto NewsWire
|
i-Business News
|
EuropeNewsWire.Net
|
iCameroon.com
|
i-Canada-News.Com
|
i-SoftwareNews.com
|
iT-NewsWire.Com
|
InvestorsNewsDesk.Com
|
i-TravelNewsWire.Com
|
LegalLaw247.com
|
Medical-NewsWire.com
|
MiningNewsWire.net
|
MoneyNewsWire.Net
|
Movie-Stars-News.Com
|
PayDayNews247.Com
|
PharmaNewsWire.Com
|
Publishing-NewsWire.Com
|
Shopping-NewsWire.com
|
Telecom-NewsWire.Net
|
Transportation-News.Com
|
USGovernment-News.Com
|
WebPosters.Net
|
Wireless-NewsWire.Com
|
Shopping-NewsWire.Com
™
- Newswire and Press Release service of GroupWeb Media LLC